---
title: >-
  Objective Disease Activity Assessment and Therapeutic Drug Monitoring is
  Lacking Prior to Biologic Therapy Changes in Routine Inflammatory Bowel
  Disease Clinical Practice: TARGET-IBD.
description: >-
  Explore this publication on real-world evidence: Objective Disease Activity
  Assessment and Therapeutic Drug Monitoring is Lacking Prior to Biologic
  Therapy…
date: '2020-01-01'
category: Publications
tags:
  - DDW
  - Oral Presentation
  - R&D
  - Care
  - Gastroenterology
  - IBD
canonical_url: >-
  https://www.pedestalhealth.com/resources/publications/ddw/objective-disease-activity-assessment-and--2020-ddw/
source: Pedestal Health
license: © 2026 Pedestal Health. All rights reserved.
slug: objective-disease-activity-assessment-and--2020-ddw
id: zTpdd1AbCJ04hLWp9ZpC3
contentType: article
---

## Challenge

This is the DDW 2020 oral presentation version of the objective disease assessment manuscript (Row 6). Earlier conference dissemination of the finding that approximately one-third of IBD patients do not undergo objective disease activity assessment or TDM prior to biologic therapy changes.

## Solution

The TARGET-IBD registry was analyzed to characterize the proportion of IBD patients with biologic dose changes or discontinuations who had objective assessment or TDM in the preceding 12 weeks, presented as a DDW 2020 oral abstract.

## Impact

High-visibility oral presentation at DDW 2020 of the objective assessment gap finding accelerates awareness among gastroenterologists and sponsors of the quality improvement opportunity in IBD monitoring practices, laying the groundwork for the subsequent BMC Gastroenterology manuscript.

### [Julie M. Crawford](/people/julie-crawford/)